🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this trial is to evaluate the progress free surviv...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2020-04-23
Trial ID
NCT04282980
Treatments Being Tested
This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study d...
Status
Completed
Location
Honor Health (GIST, mastocytosis, other solid tumors)
Start Date
2015-11
Trial ID
NCT02571036
the primary objective of this study is to assess the efficacy (progression-...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2020-11-25
Trial ID
NCT04633122
Treatments Being Tested
Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Subst...
Status
Completed
Location
Mayo Clinic Florida
Start Date
2021-09-22
Trial ID
NCT04530981
Treatments Being Tested
This is a Phase 1/2, multicenter, open-label (unless otherwise specified in...
Status
Recruiting
Location
University of Southern California - Norris Comprehensive Cancer Center
Start Date
2023-09-28
Trial ID
NCT05957367
Treatments Being Tested
to evaluate the clinical efficacy, safety and predictive factors of ripetin...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2021-05-20
Trial ID
NCT05697107
Treatments Being Tested
This is a 2-arm, randomized, placebo-controlled, double-blind, internationa...
Status
Completed
Location
HonorHealth
Start Date
2018-02-27
Trial ID
NCT03353753
Treatments Being Tested